jhavlek

Avatar

About Jennifer Havlek

This author has not yet filled in any details.
So far Jennifer Havlek has created 42 blog entries.
1 Apr, 2019

Aaron Tachibana, Chief Financial Officer

Aaron Tachibana joined Personalis as Chief Financial Officer in March 2019, with more than fifteen years of executive financial management experience at large, medium, and small cap public and private companies. Prior to Personalis, Mr. Tachibana was Chief Financial Officer at Lumentum from August 2015 to September 2018.  Lumentum is a publicly listed optical and [...]

18 Mar, 2019

Personalis to Present at ICI-IO Combinations Summit 2019

Personalis, Inc. to Present at ICI-IO Combinations Summit 2019 Menlo Park, CA – March 18, 2019 – Personalis, Inc., a leader in advanced genomics for precision oncology, today announced that they are scheduled to present at ICI-IO Combinations Summit 2019 in Boston on Wednesday, March 20, 2019 at 2:30 PM, EDT. The presentation, [...]

28 Feb, 2019

Personalis, Inc. to Present at the World Immunotherapy Congress USA 2019

Personalis, Inc. to Present at the World Immunotherapy Congress USA 2019 Menlo Park, CA – February 28, 2019 – Personalis, Inc., a leader in advanced genomics for precision oncology, today announced that they are scheduled to present at the upcoming World Immunotherapy Congress USA, which is part of the Festival of Biologics USA, [...]

5 Feb, 2019

Personalis to Present at the 2019 Immuno-Oncology 360 Conference in New York

Personalis, Inc. to Present at the 2019 Immuno-Oncology 360 Conference in New York Menlo Park, CA – February 5, 2019 – Personalis, Inc., a leader in advanced genomics for precision oncology, today announced that they are scheduled to present at the upcoming Immuno-Oncology 360° Conference in New York on Thursday, February 7, 2019 at [...]

10 Jan, 2019

RepertoireID data sheet-JAN 2019

RepertoireID An analytical module of the ImmunoID NeXT Platform Comprehensive Profiling of the TCR Repertoire T-cells are one of two types of lymphocytes (the other being B-cells) that are active cellular participants in the adaptive immune system. T-cells express T-cell receptors (TCRs) on their surface, and these receptors function [...]

9 Jan, 2019

2018 SITC: More sensitive identification of T-cell receptor beta rearrangements with an augmented transcriptome method

2018 SITC: More Sensitive Identification of T-cell Receptor Beta Arrangements with an Augmented Transcriptome Method With the increase in development and use of immunotherapies, there is also an increasing need for comprehensive immuno-genomic profiling of tumors to identify new potential biomarkers. This includes profiling of the T-cell receptor (TCR), which has traditionally not been [...]

3 Jan, 2019

Clinton Musil, MBA

Clinton Musil joined Personalis in January 2019 as Chief Business Officer.  Mr. Musil previously worked at ARMO Biosciences, where he oversaw the Company’s $147 million initial public offering and $1.6 billion sale to Eli Lilly. Clinton has expertise in corporate finance and mergers and acquisitions (M&A) from the healthcare industry, including raising several billion dollars [...]